ライフサイエンスコーパス: endoscopic

1 Endoscopic ablation and resection is highly effective fo

2 s of adverse events were similar to those of endoscopic adverse events (3.5% vs 3.0%; OR, 1.18 [95% C

3 We aimed to compare endoscopic and clinical outcomes in patients with modera

4 mptoms can be used to identify patients with endoscopic and histologic features of remission.

5 ients with BE, based on demographic data and endoscopic and histologic findings at the time of index

6 Endoscopic and histologic findings were evaluated with a

7 pared with Fn14(+/+) controls as assessed by endoscopic and histologic inflammatory scores, daily wei

8 nts in endoscopic, histologic, and combined (endoscopic and histologic remission) remission were dete

9 We assessed endoscopic and histologic remodeling and TGF-beta1 expre

10 hine learning (ML) to classify disease using endoscopic and histological data for 287 children diagno

11 This study employs mathematical modelling of endoscopic and histological data to aid diagnostic accur

12 pervised approaches confirm the need of both endoscopic and histological evidence for an accurate dia

13 inally, malignancy) and must be supported by endoscopic and imaging tools.

14 e of its eradication on disease activity and endoscopic and laboratory activity measures.

15 ies, which is suitable for three-dimensional endoscopic and laparoscopic imaging, as was demonstrated

16 labeling with fluorescent agents may assist endoscopic and surgical guidance for cancer therapy as w

17 is, focusing on pain management, the role of endoscopic and surgical intervention, and the use of pan

18 screening, and prevention of EAC as well as endoscopic and surgical management.

19 used standardized EoE scoring tools to gauge endoscopic and symptom features.

20 nd decisions about long-term use of medical, endoscopic, and diet therapies.

21 llation of compatible demographic, clinical, endoscopic, and histologic findings establish the diagno

22 and resulted in improvement in symptomatic, endoscopic, and histologic parameters using validated ou

23 tment visits, hospitalizations, and medical, endoscopic, and surgical interventions).

24 in the translational intravascular and other endoscopic applications.

25 sinus could become a disease treated with an endoscopic approach.

26 Treatment options include shunt and endoscopic approaches, which should be individualised to

27 clinical outcome questionnaire and underwent endoscopic assessment and histological evaluation of the

28 he aim of this study is to assess CT-PET and endoscopic assessment postneoadjuvant chemoradiotherapy

29 ith immunosuppressants and had more frequent endoscopic assessments.

30 Endoscopic bariatric and metabolic therapies (EBMT) are

31 BACKGROUND & AIMS: Multiple endoscopic bariatric therapies (EBTs) currently are bein

32 35 kg/m, hiatal hernia <3 cm, and absence of endoscopic Barrett disease).

33 ohn's disease, HSCT resulted in clinical and endoscopic benefit, although it was associated with a hi

34 Our results support the finding that endoscopic biliary drainage for malignant biliary obstru

35 A ERCC1, DPYD, and ERBB2 from pretherapeutic endoscopic biopsies can predict minor response to chemor

36 sk; the probability of having non-dysplastic endoscopic biopsies was 13% (5-27), whereas the probabil

37 tinal tissue specimens were obtained from an endoscopic biopsy or surgical resections performed at Jo

38 uated with magnetic resonance imaging (MRI), endoscopic biopsy, gross histological evaluation, and Hs

39 higher quantities of microbial DNA than did endoscopic brushes or biopsies using quantitative PCR (p

40 e compared fresh frozen tissue, fresh frozen endoscopic brushings, and the Cytosponge device for micr

41 Here, we used endoscopic Ca(2+) imaging to track the real-time activit

42 plastic tissue biopsies are obtained through endoscopic capture from patients with gastric, gastroeso

43 ective was to determine GED-0301's effect on endoscopic CD measures; secondary objectives included ef

44 sources and compare the results of different endoscopic centers, a new complexity grading system for

45 the comparisons of results between different endoscopic centers.

46 tudy of intestinal permeability, measured by endoscopic confocal laser endomicroscopy in 110 consecut

47 dult patients (aged 18-75 years) with active endoscopic Crohn's disease (Crohn's Disease Endoscopic I

48 lacrimal mucosal flap technique in endonasal endoscopic dacryocystorhinostomy (EES-DCR) for patients

49 Endoscopic dacryocystorhinostomy (EN-DCR) is emerging as

50 upervised ML models were developed utilising endoscopic data only, histological only and combined end

51 We investigated whether a non-endoscopic device, the Cytosponge, could be coupled with

52 years, significant progress has been made in endoscopic diagnosis and treatment of dysplasia (squamou

53 Clinical, histologic, pathologic, and endoscopic differences were investigated using a retrosp

54 The overall adverse event rate was 8.6% for endoscopic drainage (640 events) and 12.3% for percutane

55 For patients with cholangiocarcinoma, endoscopic drainage is superior in centers that perform

56 Retrospective study of patients undergoing endoscopic drainage of PFCs from 2003 to 2015.

57 The patient underwent a successful endoscopic endonasal trans-sphenoidal resection of the m

58 risks and benefits of management options of endoscopic eradication therapy (specifically adverse eve

59 Practice Advice 11: Endoscopic eradication therapy should be considered in p

60 Practice Advice 14: Patients completing endoscopic eradication therapy should be enrolled in an

61 Practice Advice 16: Endoscopists performing endoscopic eradication therapy should report audits of t

62 with LGD undergoing surveillance rather than endoscopic eradication therapy should undergo surveillan

63 Practice Advice 15: Following endoscopic eradication therapy, the biopsy protocol of o

64 lus showed no significant difference between endoscopic ETV-CPC and ventriculoperitoneal shunting wit

65 Patients underwent prospective endoscopic evaluation having previously undergone esopha

66 with ERD, and 16 patients with BE undergoing endoscopic evaluation in the United Kingdom or Greece.

67 However, endoscopic evaluation is invasive and associated with an

68 use of high-resolution radiographic studies, endoscopic evaluation, cyst fluid analysis, and novel mo

69 of 97.3% in detecting RD as compared with an endoscopic evaluation.

70 sound examination every 6 months, as well as endoscopic evaluations.

71 d from 19 sites in the United States and had endoscopic evidence of non-nodular dysplastic BE </=8 cm

72 Lesions with overt endoscopic evidence of SMIC are referred for surgery, al

73 enter cohort study of patients who underwent endoscopic examination for BE at tertiary care referral

74 eal adenocarcinoma (EAC) within 1 year of an endoscopic examination that produced negative findings.

75 s verified by means of other methods such as endoscopic examinations, endovascular procedures, or sur

76 Gastric polyps are frequently encountered on endoscopic examinations.

77 nophils in biopsies, changes in symptoms and endoscopic features are becoming important targets of th

78 Although endoscopic features correspond to histologic features, s

79 he clinical setting, it is possible that the endoscopic finding of a longitudinal mid-esophageal ulce

80 The inclusion criteria were: 1) endoscopic findings of GU and biopsy histological examin

81 Demographic data, laboratory parameters and endoscopic findings were recorded.

82 Based on the endoscopic findings, 34 of 64 (53%) eyes were identified

83 Imaging findings were compared with endoscopic findings, being the gold standard for the ass

84 ith low risk of progression suitable for non-endoscopic follow-up.

85 This study aimed to determine the endoscopic frequency of esophageal and gastric cancers a

86 thesised that gastric juice and percutaneous endoscopic gastrostomy (PEG) feeding devices might yield

87 Percutaneous endoscopic gastrostomy (PEG) is an effective and safe mo

88 m fifteen CF patients receiving percutaneous endoscopic gastrostomy feeding.

89 surface erosions, intercellular space width, endoscopic grade of esophagitis, esophageal acid exposur

90 High-level experience with endoscopic harvesting performed by a dedicated specialis

91 For detection of endoscopic healing (MCSe </= 1), colonoscopy found persi

92 We also examined the degree of endoscopic healing at 1 year.

93 he proportions of patients with steroid-free endoscopic healing at week 16 were 35% in the methotrexa

94 on is the standard technique used to measure endoscopic healing in ulcerative colitis (UC) clinical t

95 When endoscopic healing was defined as MCSe of 0, the concord

96 When endoscopic healing was defined as MCSe of 0, there were

97 clinical subscore </=2 with no item >1) and endoscopic healing without steroids at weeks 16 and/or 2

98 ssion, defined as resolution of symptoms and endoscopic healing.

99 Complete endoscopic healting was noted in 19 (50%, 34-66) of 38 p

100 ups that underwent standard, visually guided endoscopic hemostasis (control, n = 76), or endoscopic h

101 endoscopic hemostasis (control, n = 76), or endoscopic hemostasis assisted by Doppler monitoring of

102 nts with cirrhosis, who underwent successful endoscopic hemostasis for variceal bleeding, covered TIP

103 rates of lesion rebleeding within 30 days of endoscopic hemostasis in the control group (26.3%) vs th

104 lcers or other lesions, Doppler probe guided endoscopic hemostasis significantly reduced 30-day rates

105 Despite successful endoscopic hemostasis, there is a significant risk of re

106 s have been used for risk stratification and endoscopic hemostasis.

107 ith SMIC, and examined lesions without overt endoscopic high-risk signs to determine factors associat

108 s used as a continuous variable, patients in endoscopic, histologic, and combined (endoscopic and his

109 from an EoE-like disease were evaluated with endoscopic, histologic, functional, and quantitative imm

110 ic data only, histological only and combined endoscopic/histological data yielding classification acc

111 ep-learning model has potential for not only endoscopic image recognition but for other forms of medi

112 Mini-endoscopic images revealed that hgd40 and anti-TNF reduc

113 We show that this novel endoscopic imaging modality is able to provide a number

114 eviously, we demonstrated successful ex vivo endoscopic imaging of human bladder cancer by topical (i

115 tive mapping of Dox distribution in vivo via endoscopic imaging.

116 Endoscopic improvement was observed in 37% of participan

117 eum or colon, or both, and a Crohn's Disease Endoscopic Index of Severity (CDEIS) of at least 7 (>/=4

118 opic subscores (MCSe) and ulcerative colitis endoscopic index of severity (UCEIS) scores from the rec

119 endoscopic Crohn's disease (Crohn's Disease Endoscopic Index of Severity [CDEIS] >6; sum of CDEIS su

120 Mucosal healing was defined as CD Endoscopic Index of Severity of 0 in CD or Mayo endoscop

121 (those with a decrease in the Crohn disease endoscopic index of severity score of 25-44 before treat

122 timicrobial prophylaxis to surgery including endoscopic injection of a bulking agent and minimally in

123 ht still contain SMIC that is not visible on endoscopic inspection (covert SMIC).

124 Endoscopic intervention is limited to those patients wit

125 As there was no active bleeding, no endoscopic intervention was performed.

126 addition to their expertise in nutrition and endoscopic interventions.

127 g, and could further benefit a wide range of endoscopic investigations through intra-operative guidan

128 Surgical and endoscopic management of duodenal neoplasia is difficult

129 DPDS has a significant effect on endoscopic management of PFCs as more patients required

130 Endoscopic methods (gastroscopy and colonoscopy) are con

131 Endoscopic mucosal resection (EMR) is currently the most

132 or endoscopic submucosal dissection than for endoscopic mucosal resection (EMR).

133 rative effectiveness of esophagectomy versus endoscopic mucosal resection followed by radiofrequency

134 Endoscopic mucosal resection of two polyps from the card

135 rm outcomes for patients undergoing per-oral endoscopic myotomy (POEM) after our initial 15-case lear

136 s review is to describe a place for per-oral endoscopic myotomy (POEM) among the currently available

137 arge series of patients treated with peroral endoscopic myotomy (POEM) in a single European center.

138 pathologic findings of surgical (n = 23) and endoscopic (n = 32) biopsy specimens were used as the re

139 spray compared with mometasone alone reduced endoscopic nasal polyp burden after 16 weeks.

140 Change in endoscopic nasal polyp score (range, 0-8; higher scores

141 at Week 25 based on a composite end point of endoscopic nasal polyp score and nasal polyposis severit

142 ement in nasal polyposis severity VAS score, endoscopic nasal polyp score, all individual VAS symptom

143 hange in nasal polyposis severity VAS score, endoscopic nasal polyp score, improvement in individual

144 Transmural endoscopic necrosis was defined as grade 3b injuries; si

145 ssue and 6 microm transverse resolution) for endoscopic OCT imaging at 800 nm.

146 Endoscopic optical coherence tomography (OCT) has emerge

147 None of the baseline demographic, clinical, endoscopic or esophageal acid exposure characteristics w

148 In patients with EoE, endoscopic or histologic remission can be identified wit

149 No endoscopic or histological anomalies were found at the a

150 sease, who have had negative or inconclusive endoscopic or imaging studies.

151 free clinical remission for 3 months with no endoscopic or radiological evidence of intestinal inflam

152 ntrations of FCP correlate with clinical and endoscopic outcomes of patients with moderate to severe

153 of fecal calprotectin (FCP) and clinical and endoscopic outcomes of patients with moderate to severe

154 ohn's disease results in better clinical and endoscopic outcomes than symptom-driven decisions alone.

155 Clinical and endoscopic outcomes were assessed at week 8 using the Ma

156 s between FCP concentration and clinical and endoscopic outcomes, and to determine the FCP cut-off co

157 ted precut sphincterotomy (PS) combined with endoscopic papillary balloon dilation (EPBD) for CBD sto

158 who had treated by endoscopic sphincterotomy/endoscopic papillary balloon dilation (EST/EPBD) with ne

159 Children present with symptoms and endoscopic patterns characteristic of inflammation, wher

160 olumetrically-reconstructed image stacks and endoscopic perspective videos, represents an improvement

161 Endoscopic placement of multiple plastic stents in paral

162 Fiberoptic technology dramatically changed endoscopic practice.

163 ontrolled trial to determine whether Doppler endoscopic probe monitoring of blood flow improves risk

164 bilirubin (HR 5.79, p 0.008) and lack of an endoscopic procedure done (HR 4.40, p <0.001).

165 tography (ERCP) is a technically challenging endoscopic procedure, harboring a wide range of complexi

166 of surgical myotomy, with the benefits of an endoscopic procedure.

167 segment ablated circumferentially) or a sham endoscopic procedure; patients in the sham group were of

168 small intestine, but its use with respect to endoscopic procedures and cross-sectional imaging varies

169 he initial SFGED, a step-up strategy reduced endoscopic procedures and diagnostic process time by 20%

170 Endoscopic procedures have increasingly been used in the

171 Endoscopic procedures have not been proven as effective.

172 likely to have adverse events compared with endoscopic procedures performed at the same center (5.7%

173 For pancreatic cancer, endoscopic procedures were associated with a lower rate

174 ndred thirty-eight biopsy specimens from 246 endoscopic procedures were evaluated over 10 years.

175 S, stratified by stricture etiology and with endoscopic reassessment for resolution every 3 months (p

176 nd a >/=70-point increase from baseline, and endoscopic recurrence (Rutgeerts score >/=i2, determined

177 tion of patients in the infliximab group had endoscopic recurrence based only on Rutgeerts scores >/=

178 tion of patients in the infliximab group had endoscopic recurrence compared with the placebo group (3

179 Endoscopic recurrence was a major secondary end point.

180 However, infliximab does reduce endoscopic recurrence.

181 Moreover, 64% (32/50) showed endoscopic reduction in the length of BE.

182 also significantly less in the group showing endoscopic reduction of BE (%time pH < 4, 0.2 vs 3.6, P

183 Multicenter (8 endoscopic referral centers), open-label, parallel, rand

184 , respectively; kappa coefficient, 0.44) and endoscopic remission (0.79 and 0.75, respectively; kappa

185 re in clinical remission (41.3%), 79 were in endoscopic remission (29.7%), and 75 were in histologic

186 <5 eosinophils/median high-power field); and endoscopic remission as absence of white exudates, moder

187 A symptom score of 20 identified patients in endoscopic remission with 65.1% accuracy and histologic

188 full control of these diseases (clinical and endoscopic remission), with the final aim of blocking th

189 mg/kg; clinical remission, 64 vs 617 mg/kg; endoscopic remission, 44 vs 489 mg/kg; and mucosal heali

190 s were 0.80 for clinical remission, 0.81 for endoscopic remission, and 0.78 for mucosal healing.

191 e of CSF leak which is required for surgical/endoscopic repair of the CSF fistula.

192 (specifically adverse events associated with endoscopic resection and ablation), and ongoing surveill

193 finition endoscopy and capable of performing endoscopic resection and ablation.

194 ic infected individuals vs individuals after endoscopic resection of early gastric cancer), demograph

195 62; 95% CI: 0.49-0.79) and individuals after endoscopic resection of gastric cancers (pooled incidenc

196 with intent to preserve the larynx by using endoscopic resection or radiation therapy, with either l

197 Practice Advice 9: Endoscopic resection should be performed in Barrett's es

198 A complete endoscopic response (cER) was no residual mucosal abnorm

199 d be found by cholangiogram (ERC) during the endoscopic retrograde cholangio-pancreatiographic (ERCP)

200 h risk to develop septic complications after endoscopic retrograde cholangiography (ERC).

201 endoscopies, 1109 lower endoscopies, and 58 endoscopic retrograde cholangiopancreatographies).

202 Difficult biliary cannulation in endoscopic retrograde cholangiopancreatography (ERCP) ca

203 ndings with histopathology/surgical findings/Endoscopic Retrograde CholangioPancreatography (ERCP) fi

204 loon-assisted enteroscopy allows therapeutic endoscopic retrograde cholangiopancreatography (ERCP) in

205 Endoscopic retrograde cholangiopancreatography (ERCP) is

206 struction can be performed endoscopically by endoscopic retrograde cholangiopancreatography (ERCP) or

207 smitted by contaminated duodenoscopes during endoscopic retrograde cholangiopancreatography (ERCP) pr

208 an episode of choledocholithiasis requiring endoscopic retrograde cholangiopancreatography (ERCP) wi

209 ancreatitis in high-risk patients undergoing endoscopic retrograde cholangiopancreatography (ERCP), b

210 creases the occurrence of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).

211 hacin reduces the risk of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).

212 Timing of endoscopic retrograde cholangiopancreatography and outco

213 ples from 50 patients undergoing therapeutic endoscopic retrograde cholangiopancreatography at univer

214 Endoscopic retrograde cholangiopancreatography confirmed

215 Timing of endoscopic retrograde cholangiopancreatography does not

216 tions associated with duodenoscopes used for endoscopic retrograde cholangiopancreatography have high

217 tors in AC, evaluate the effect of timing of endoscopic retrograde cholangiopancreatography on clinic

218 16 patients over the course of 40 weeks via endoscopic retrograde cholangiopancreatography procedure

219 le metallic stents (cSEMS) may require fewer endoscopic retrograde cholangiopancreatography procedure

220 ained in patients who underwent preoperative endoscopic retrograde cholangiopancreatography since the

221 In the validation cohort, timing of endoscopic retrograde cholangiopancreatography was not s

222 ent was transferred to our hospital where an endoscopic retrograde cholangiopancreatography with bili

223 tients with choledocholithiasis treated with endoscopic retrograde cholangiopancreatography with lapa

224 ch the availability and size of pretreatment endoscopic samples are limiting.

225 We believe that alarm symptoms and endoscopic scanning programs require new, region-specifi

226 score >1, and mucosal healing was defined as endoscopic score </=1.

227 tively recruited and grouped according to an endoscopic score and therapy response.

228 D concentrations were compared with the Mayo endoscopic score, the total Mayo score, and histologic a

229 Clinical and endoscopic scoring systems have helped to standardize di

230 (PVT), the usually recommended strategy for endoscopic screening and management of varices is the sa

231 geal cancer has remained a large burden, and endoscopic screening is expected to reduce esophageal ca

232 n in esophageal cancer mortality risk due to endoscopic screening, which may have significant implica

233 organizational factors that affect choice of endoscopic sedation.

234 es were 39% vs 3% (P < .0001), and change in endoscopic severity score was -3.8 vs 0.4 (P < .0001).

235 Endoscopic severity scores and safety parameters were as

236 any time correlated with lower fibrosis and endoscopic severity.

237 udies have not examined the impact of CRS or endoscopic sinus surgery (ESS) upon asthma quality of li

238 rol criteria at 3-5 years after a functional endoscopic sinus surgery (FESS) and correlate these data

239 Although functional endoscopic sinus surgery is an effective means of treati

240 ate of extraction of CBDS who had treated by endoscopic sphincterotomy/endoscopic papillary balloon d

241 Endoscopic stenting in PSC should be reserved for situat

242 oscopic Index of Severity of 0 in CD or Mayo endoscopic sub-score of 0-1 for patients with UC.

243 e developed a novel artificial simulator for endoscopic submucosal dissection (ESD) as a bridge betwe

244 Endoscopic submucosal dissection (ESD) is a newer proced

245 covert SMIC risk might be better suited for endoscopic submucosal dissection than for endoscopic muc

246 m decisions on which patients should undergo endoscopic submucosal dissection, EMR, or surgery.

247 rge (with a total Mayo score >/=6 and a Mayo endoscopic subscore >/=2) who had failed or were intoler

248 ST2 levels correlated with Mayo clinical and endoscopic subscore, mucosal ST2 and FC (Rs = 0.57, 0.66

249 by ELISA and correlated to Mayo clinical and endoscopic subscore.

250 Central readers determined Mayo Clinic endoscopic subscores (MCSe) and ulcerative colitis endos

251 y and safety of Natural Orifice Transluminal Endoscopic Surgery (NOTES) appendectomy, and to analyze

252 Changes were supported for the use of endoscopic surgical resection in patients with limited d

253 Patients with diverticulitis should undergo endoscopic surveillance for colon cancer.

254 h Barrett's oesophagus will not progress and endoscopic surveillance is invasive, expensive, and frau

255 Endoscopic surveillance of patients with BE likely impro

256 eradication therapy should be enrolled in an endoscopic surveillance program.

257 HGD: (1) esophagectomy, (2) EMR-RFA, and (3) endoscopic surveillance.

258 Using a simultaneous fluorescence-Raman endoscopic system (FRES), we herein demonstrate its pote

259 the efficacy and safety of pharmacologic or endoscopic therapies as primary prophylaxis or that prev

260 cation, magnetic sphincter augmentation, and endoscopic therapies can benefit patients with well-char

261 garding the durability and role of different endoscopic therapies for dysplastic Barrett's oesophagus

262 nt for development of medical, surgical, and endoscopic therapies for GERD.

263 Endoscopic therapies have a role in temporizing active v

264 We analyzed data from a multicenter study of endoscopic therapy to identify factors associated with p

265 e resolution after no more than 12 months of endoscopic therapy.

266 g medical conditions which require immediate endoscopic therapy.

267 Endoscopic third ventriculostomy with choroid plexus cau

268 ichtenstein using local anesthesia (LLA) and endoscopic total extra-peritoneal repair (TEP) under gen

269 dergoing surgical repair (33%) compared with endoscopic treatment (65%) and conservative management (

270 ve been presented, but do not include modern endoscopic treatment modalities.

271 on the impact of DPDS in patients undergoing endoscopic treatment of PFCs are limited.

272 cirrhosis and EVB refractory to medical and endoscopic treatment.

273 ients with EVB uncontrolled with medical and endoscopic treatment.

274 From pretherapeutic endoscopic tumor biopsies, ERCC1 rs11615 single-nucleoti

275 ene(R) Microspheres - 250 mum in size before endoscopic tumour excision to reduce intra-operative ble

276 Endoscopic ultrasonography and endoscopic ultrasonograph

277 esophagus was assessed by endoscopy, biopsy, endoscopic ultrasonography, and high-resolution impedanc

278 Endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration

279 his review aims to record pancreaticobiliary endoscopic ultrasound (EUS) and other imaging modalities

280 Endoscopic ultrasound (EUS) has gained increasing attent

281 Endoscopic ultrasound (EUS) revealed a heteroechoic soli

282 BACKGROUND & AIMS: Endoscopic ultrasound (EUS)-guided chemoablation with et

283 conjunction with cross-sectional imaging and endoscopic ultrasound as part of the preoperative risk s

284 tomatic at diagnosis and 363 (63%) underwent endoscopic ultrasound at least once.

285 An upper endoscopy with endoscopic ultrasound was performed and fine-needle aspi

286 Advanced imaging includes endoscopic ultrasound with cyst fluid analysis and cytol

287 role of colonoscopy, flexible sigmoidoscopy, endoscopic ultrasound, fecal testing and CT colonography

288 thods Cyst fluid samples obtained by routine endoscopic ultrasound-guided aspiration were used for th

289 The feasibility of detecting these miRNAs in endoscopic ultrasound-guided fine-needle aspiration samp

290 6 chronic pancreatitis, 15 C), and set 2-95 endoscopic ultrasound-guided fine-needle aspirations (60

291 c resonance cholangiopancreatography, and/or endoscopic ultrasound.

292 this multicenter randomized trial, long-term endoscopic variceal ligation (EVL) or glue injection + b

293 Endoscopic variceal ligation plus beta-blockers (EVL+BB)

294 recommendation for primary prophylaxis with endoscopic variceal ligation, sclerotherapy, or nonspeci

295 eeding, after hemodynamic stabilization upon endoscopic, vasoactive, and antibiotic treatment.

296 overed stents in patients receiving standard endoscopic, vasoactive, and antibiotic treatment.

297 Current consensus statements maintain that endoscopic vein harvesting (EVH) should be standard care

298 CTC results were revealed after endoscopic visualization of sequential colonic segments,

299 he remaining 2 eyes had vitreous hemorrhage; endoscopic vitrectomy was done in them to detect an inop

300 al procedure and 24 (37.5%) patients who had endoscopic vitreoretinal procedures initially before und

301 inage procedures (surgical, percutaneous, or endoscopic) were identified as protective (AOR, 0.08; 95